NCT06687902

Brief Summary

The aim of the study is to evaluate the added value of digital breast tomosynthesis (DBT) in the characterization of breast lesions.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 9, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 11, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 14, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2025

Completed
Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

11 months

First QC Date

November 11, 2024

Last Update Submit

November 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compare DBT with traditional mammography in terms of diagnostic accuracy, sensitivity, and specificity for detecting and differentiating benign and malignant breast lesions

    1 hour

Study Arms (1)

Patients with breast lesions

EXPERIMENTAL
Diagnostic Test: Digital breast tomosynthesis

Interventions

In digital breast tomosynthesis (DBT), images are acquired using a specialized X-ray tube that moves in an arc around the breast. This technique captures multiple low-dose images from various angles, typically within a 15° to 60° range. These images are then reconstructed into 1-mm slices to create a 3D representation of the breast, allowing for detailed layer-by-layer evaluation. The number of images acquired varies depending on the size of the breast and the specifications of the equipment but generally ranges from 10 to 25 projections, captured within a few seconds.

Patients with breast lesions

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with mammographic breast lesions of BIRADS III, IV.
  • Dense breast in patients with complaints (BIRADS 0) which needed further assessment.

You may not qualify if:

  • Pregnant females to avoid the hazards of ionizing radiation to the fetus.
  • Patients with known metastatic breast cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University

Sohag, 82749, Egypt

Location

MeSH Terms

Interventions

Mammography

Intervention Hierarchy (Ancestors)

RadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.B.B.Ch

Study Record Dates

First Submitted

November 11, 2024

First Posted

November 14, 2024

Study Start

October 9, 2024

Primary Completion

September 10, 2025

Study Completion

December 6, 2025

Last Updated

November 14, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

for risk of participant data identification and for privacy concerns

Locations